A Study of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older
Clinical trial NCT01440387 · COMPLETED
Trial details
- NCT number
- NCT01440387
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-30
- Primary completion
- 2011-10-22
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.